-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation